Dr. Gerda Silling

No current affiliations available for this person. The person is no longer active at the university.

Publications

Treatment strategies in patients with AML or high-risk myelodysplastic syndrome relapsed after Allo-SCT Sauer T, Silling G, Groth C, Rosenow F, Krug U, Gorlich D, Evers G, Albring J, Besoke R, Mesters RM, Muller-Tidow C, Kessler T, Buchner T, Berdel WE, Stelljes M (2015) In: Bone Marrow Transplantation, 50(4). Research article (journal)
Population pharmacokinetics of liposomal amphotericin B and caspofungin in allogeneic hematopoietic stem cell recipients Würthwein G, Young C, Lanvers-Kaminsky C, Hempel G, Trame M, Schwerdtfeger R, Ostermann H, Heinz W, Cornely O, Kolve H, Boos J, Silling G, Groll A (2012) In: Antimicrobial Agents and Chemotherapy, 56(1). Research article (journal)
Randomized comparison of safety and pharmacokinetics of caspofungin, liposomal amphotericin B, and the combination of both in allogeneic hematopoietic stem cell recipients. Groll AH, Silling G, Young C, Schwerdtfeger R, Ostermann H, Heinz WJ, Gerss J, Kolve H, Lanvers-Kaminsky C, Vieira Pinheiro JP, Gammelin S, Cornely OA, Wuerthwein G (2010) In: Antimicrobial Agents and Chemotherapy, 54(10). Research article (journal)
A phase II dose escalation study of caspofungin for invasive aspergillosis Cornely O, Vehreschild JJ, Ruping M, Arenz D, Schwartz S, Heussel OP, Silling G, Mahne M, Franklin J, Harnischmacher U, Wilkens A, Farowski F, Karthaus M, Lehrnbecher T, Ullmann A, Hallek M, Groll A (2010) In: Bone Marrow Transplantation, 45 Suppl.. Research article (journal)
A phase II dose escalation study of caspofungin for invasive aspergillosis Cornely OA, Vehreschild JJ, Ruping MJGT, Arenz D, Schwartz S, Heussel CP, Silling G, Mahne M, Franklin J, Harnischmacher U, Wilkens A, Farowski F, Karthaus M, Lehrnbecher T, Ullmann AJ, Hallek M, Groll A (2010) In: Mycoses, 53(5). Research article (journal)

Show all publications